Dr. Tom Moorcroft

Emerging Therapies for Tick-borne Illnesses (1 CEU)

TBD

Tick-borne co-infections are becoming increasingly appreciated as causes of human disease and morbidity. Once thought to be relatively rare, researchers are now finding that co-infection of ticks, such as Ixodes scapularis, occurs “more frequently than expected, resulting in enhanced human exposure to multiple infections that can cause more severe symptoms and sometimes make diagnosis more difficult” [Dunn 2014].

This knowledge has helped clinicians better define the often complex presentation of patients with persistent tick-borne disease and opened new pathways for effective treatment and management of these patients.

Along with this greater understanding of the frequency of tick co-infection, other researchers have also looked for more effective treatment approaches for persistent co-infections. In the past 3 years there have been research breakthroughs in the utilization of both pharmacologic and botanical anti-microbials that have led to significant improvements in patient outcomes, decreased patient suffering and decreased burden of illness to society.

Reason for topic:

1. To realize tick co-infection leads to greater human exposure to multiple

pathogens from a single tick attachment and that this increases the complexity

of symptoms and diagnosis.

2. To realize log, stationary and other persister forms of tick-borne co-infections

require different treatment approaches.

3. To realize there are evidence-based pharmacologic and botanical treatments for

tick-borne co-infections.

Learning objectives:

1. To develop an understanding of the frequency of tick co-infection and the

increased risk of patient co-infection from tick bite, including how this impacts

presentation of symptoms and laboratory testing.

2. To develop an understanding of log and stationary bacterial growth as well as

other bacterial persister forms and how each phase requires different treatment

approaches.

3. To develop an understanding of the most up to date, evidence-based growing,

stationary and persister co-infection treatments

Dr. Tom Moorcroft, DO is a global leader in solving complex medical mysteries. He completed his undergraduate studies at the University of Vermont before attending the University of New England College of Osteopathic Medicine (UNECOM).

Education

University of Vermont – Bachelor’s of Science – Ecology & Wildlife Management
Doctor of Osteopathic Medicine – University of New England College of Osteopathic Medicine (UNECOM)
Medical Gross Anatomy & Osteopathic Manipulation Fellowship – UNECOM
Medical Neuroanatomy Fellowship – UNECOM
International Lyme and Associated Diseases Society (ILADS) Physician Training Program – Mentored with Dr. Richard Horowitz and Dr. Charles Ray Jones
Recognition of Proficiency in Osteopathy in the Cranial Field by the Osteopathic Cranial Academy

Board Certification

Family Practice and Osteopathic Manipulative Treatment

Employment

Origins Of Health, Berlin, CT. Founder, Chief Medical Officer, Physician
- Registered Out-Of-State Telehealth Provider for the State of Florida
Has treated thousands of patients with complex, chronic medical mysteries over the past 12 years
Started in medicine in 1995 – learning, then teaching wilderness medicine, working on the ambulance and then in the emergency room. Dr. Tom not only has experience as a physician, but as a member of the nursing staff, caring for critically ill patients

Professional Volunteer Work

Osteopathic Cranial Academy – Director, Chair of IT and Membership, Member of several other committees
Osteopathic Cranial Academy – member of the teaching faculty
ILADS – Acting President, Director, Chair of Membership Committee, Member of several other committees
ILADS Evidence Based Fundamentals Program – member of the working group that developed this program
ILADEF Physician Training Program Physician Mentor (youngest ever)
Connecticut PANDAS/PANS Advisory Council

Key Publication

Lee SH, Vigliotti JS, Vigliotti VS, Jones W, Moorcroft TA, Lantsman K. DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections. Int J Mol Sci. 2014;15(7):11364–11386. Published 2014 Jun 25. doi:10.3390/ijms150711364

Lectures

Tick-borne Co-infections – Emerging Pharmacologic, Herbal and other integrative treatments

PANS/PANDAS/Infection-Induced Autoimmune Encephalitis

The Glymphatic System and Brain Detoxification

Healing Mindset – Aligning Your Mindset & Health Goals for Optimal Results

MeditationRx – Awaken Healing and Achieve Rapid Transformation from Chronic Conditions through Chronic Healing Meditation

These are available in a 40-60 minute keynote, 90 minute break out, and up to 60 minute customized interview.

For those interested in booking Dr. Tom, email support@tommoorcroft.com or contact our team at 860-438-7096.